Process Chemistry in the Pharmaceutical Industry - C&EN Global

Jan 3, 2005 - Advertisements that appeared within the print issues of Chem. Eng. News have been included in the C&EN Archives to provide a ...
0 downloads 0 Views 414KB Size
Process Chemistry in the Pharmaceutical Industry FEBRUARY 6 - 9 , 2005 I MIAMI, FL

©

| or t h e fourth annual A C S ProSpectives conference o n Process Chemistry, chairs Margaret Faul, Associate Director of Chemical Process R & D at A M G E N , a n d Joseph Armstrong, Director of Process Research at Merck, have created a conference that integrates three key areas of process chemistry: practical aspects of d r u g development; leading technologies from academia; and strategies for advancing new chemical entities t h r o u g h t h e regulatory process. D u r i n g the conference, top academics will discuss new technology and methods for asymmetric synthesis, organometallic catalysis, and automation, and leading pharmaceutical industry chemists will highlight case studies that detail how using these methods contributed to getting their novel compounds to market successfully. A senior F D A official will b e o n h a n d to discuss t h e regulatory aspects of d r u g discovery d u r i n g t h e popular regulatory roundtable, as will t h e a u t h o r of a leading article o n A P I starting materials strategy.

CONFIRMED SPEAKERS • David Evans of Harvard and Stephen King of Abbott will be keynote speakers • Gary Molander of Penn, Ian Paterson of Cambridge, Eric Sorenson of Princeton and Anthony Barrett of Imperial College of London will speak on asymmetric synthesis • Stephen Buchwald of MIT, Kai Rossen of Degussa and Felix Spindler of Solvias will speak on asymmetric catalysis

• Joel Hawkins of Pfizer, Jennifer Rutherford of Pfizer, and Tom Boussie of Symyx will speak on technology and automation • John Simmons of the FDA and Jean Wyvratt of Merck will host the regulatory roundtable SHORT COURSES: • Peter Wipf of Pitt on Heterocyclic Chemistry • Allan Myerson of I IT on Crystallization

• Vittorio Farina of Boehringer-lngelheim, Frank Fang of Eisai, Peter Dunn of Pfizer, SophieDorothee Clas of Merck Frosst and Lushi Tan of Merck will present pharmaceutical case studies

• Huw Davies of SU NY-Buffalo on Catalysis

A E S S R D S PEICTIVES Where chemistry crosses disciplines to advance science

Goto W W W . A C S P R D S P E C T I V E S . D R G formore conference details and to register. Don't forget to sign up for new conference alerts, too.